We are live on
!
Find out more
CA
Corriente Advisors Portfolio holdings
AUM
$9.53M
1-Year Est. Return
805.26%
This Fund
S&P 500
This Quarter
Est. Return
+2.55%
1 Year Est. Return
+805.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$185M
AUM Growth
-$86.2M
(-32%)
Cap. Flow
-$89.5M
Cap. Flow
% of AUM
-48.25%
Top 10 Holdings %
Top 10 Hldgs %
92.79%
Holding
19
New
9
Increased
–
Reduced
6
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QuantumScape Corp
QS
|
+$10.9M |
| 2 |
Coinbase
COIN
|
+$10.4M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$8.03M |
| 4 |
Kratos Defense & Security Solutions
KTOS
|
+$7.29M |
| 5 |
MP Materials
MP
|
+$3.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
+$26M |
| 2 |
Teledyne Technologies
TDY
|
+$22.8M |
| 3 |
Replimune Group
REPL
|
+$21.4M |
| 4 |
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
|
+$21.2M |
| 5 |
Meta Platforms (Facebook)
META
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.15% |
| 2 | Healthcare | 36.46% |
| 3 | Financials | 5.46% |
| 4 | Consumer Discretionary | 5.32% |
| 5 | Industrials | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAXR
1
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $76.7M | 41.35% |
1,920,333
-729,667
| -28% | -$26M |
|
2
Cue Biopharma
CUE
$131M
| $17.3M | 9.34% |
49,566
-35,402
| -42% | -$13.7M |
|
|
3
Replimune Group
REPL
$859M
| $17.3M | 9.32% |
449,879
-625,121
| -58% | -$21.4M |
|
|
4
Coinbase
COIN
$41.4B
| $10.1M | 5.46% |
+40,000
| New | +$10.4M |
|
|
RETA
5
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $10.1M | 5.43% |
+71,115
| New | +$8.03M |
|
|
6
QuantumScape Corp
QS
$3.6B
| $9.87M | 5.32% |
+337,316
| New | +$10.9M |
|
7
Lantern Pharma
LTRN
$36.6M
| $9.58M | 5.17% |
656,364
-57,442
| -8% | -$887K |
|
8
Cardiff Oncology
CRDF
$60.2M
| $9.2M | 4.96% |
1,383,500
-1,401,910
| -50% | -$11.9M |
|
|
9
Kratos Defense & Security Solutions
KTOS
$8.63B
| $7.86M | 4.24% |
+275,738
| New | +$7.29M |
|
|
10
MP Materials
MP
$8.05B
| $4.05M | 2.19% |
+110,000
| New | +$3.42M |
|
|
HIMX
11
Himax Technologies
HIMX
$2.23B
| $3.33M | 1.8% |
+200,000
| New | +$2.64M |
|
12
CRISPR Therapeutics
CRSP
$4.71B
| $3.24M | 1.75% |
+20,000
| New | +$2.43M |
|
13
Iridium Communications
IRDM
$4.95B
| $3.2M | 1.73% |
+80,000
| New | +$3.11M |
|
14
Roblox
RBLX
$37B
| $2.7M | 1.46% |
+30,000
| New | +$2.41M |
|
15
DiaMedica Therapeutics
DMAC
$393M
| $906K | 0.49% |
203,641
-666,587
| -77% | -$5.47M |
|
16
EyePoint Inc
EYPT
$1.12B
| – | – |
-200,000
| Closed | -$2.03M |
|
|
17
Meta Platforms (Facebook)
META
$1.64T
| – | – |
-50,000
| Closed | -$14.7M |
|
|
18
Teledyne Technologies
TDY
$29.4B
| – | – |
-55,000
| Closed | -$22.8M |
|
|
TFFP
19
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| – | – |
-62,627
| Closed | -$21.2M |
|
Similar funds
SCM
FWM
TOPU
TGI
GIP
LCMP
SCM
TA
Corriente Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Corriente Advisors held 19 positions worth $185M, down 32% from $272M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Corriente Advisors withdrew a net $89.5M in Q2 2021, closing 4 positions and reducing 6 holdings. Its most notable exit was Teledyne Technologies, an estimated $22.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Corriente Advisors opened a new position in QuantumScape Corp worth $9.87M.
- Corriente Advisors's largest Q2 2021 buy was QuantumScape Corp: 337,316 shares worth $9.87M.
- Corriente Advisors's biggest Q2 2021 reduction was Maxar Technologies Inc. Common Stock, cutting an estimated $26M.
- Corriente Advisors fully exited Teledyne Technologies in Q2 2021, selling an estimated $22.8M.
- Corriente Advisors's ten largest holdings make up 93% of its $185M portfolio in Q2 2021.
- Corriente Advisors opened 9 new positions and closed 4 in Q2 2021.
- Corriente Advisors's portfolio value fell 32% quarter-over-quarter to $185M.
Based on Corriente Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.